|1|Optimal management of germ cell cancer: more a matter of expertise than of chemotherapy regimen. (25447105)
de Wit R.
|2|Salvage chemotherapy with gemcitabine plus oxaliplatin for patients with testicular germ cell cancer. (24647526)
Uchida M.... Nishiyama H.
|3|A practice-changing step forward in germ-cell cancer? (25456352)
|4|Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling. (25382245)
Rijlaarsdam M.A.... Looijenga L.H.
|5|Role of stem cell proteins and microRNAs in embryogenesis and germ cell cancer. (23784843)
Eini R.... Looijenga L.H.
|6|Association of polymorphisms in genes encoding hormone receptors ESR1, ESR2 and LHCGR with the risk and clinical features of testicular germ cell cancer. (22245602)
Brokken L.J.... Giwercman A.
|7|Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer. (23071246)
Brabrand S.... Lehne G.
|8|Germ cell cancer presenting as gastrointestinal bleeding and developing brain metastases: case report and review of the literature. (23148621)
Fu S.... Gotlieb V.
|9|Burden or relief: do second-opinion centers influence the quality of care delivered to patients with testicular germ cell cancer? (19931248)
Schrader M.... Heidenreich A.
|10|Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. (19010497)
Ellinger J.... Bastian P.J.
|11|High-dose chemotherapy plus stem cell transplantation in advanced germ cell cancer: a review. (19303697)
Connolly R.M.... McCaffrey J.A.
|12|European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. (18191324)
Krege S.... von der Maase H.
|13|Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study. (18936476)
Garcia-del-Muro X.... GermA!-Lluch J.R.
|14|Association of the polymorphism of the CAG repeat in the mitochondrial DNA polymerase gamma gene (POLG) with testicular germ-cell cancer. (18632724)
Blomberg Jensen M.... Rajpert-De Meyts E.
|15|Estrogens promote human testicular germ cell cancer through a membrane-mediated activation of extracellular regulated kinase and protein kinase A. (18039775)
Bouskine A.... Fenichel P.
|16|Clinical impact of MDR1-expression in testicular germ cell cancer. (18004247)
Schrader A.J.... Heidenreich A.
|17|Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer. (16234294)
Voigt W.... Schmoll H.J.
|18|The efficacy of different follow-up strategies in clinical stage I Non-seminomatous Germ Cell Cancer: a Markov simulation study. (15964134)
Spermon J.R.... Kiemeney L.A.
|19|A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial. (15999102)
Mead G.M.... Mason M.
|20|Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer. (15627215)
Wierecky J.... Bokemeyer C.
|21|Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients. (15900213)
Nuver J.... Gietema J.A.
|22|Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer. (16301122)
Beck S.D.... Donohue J.P.
|23|High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer. (15803005)
Chaudhary U.B.... Small E.J.
|24|Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer. (15365067)
Rick O.... Beyer J.
|25|Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning. (15026798)
van Dijk M.R.... Habbema J.D.
|26|Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group. (14701772)
Kollmannsberger C.... Bokemeyer C.
|27|Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study. (15105386)
Eberhard J.... Giwercman A.
|28|Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ. (12752243)
Oliver R.T.... Shamash J.
|29|Physical activity in long-term survivors of germ-cell cancer. (12763205)
Sleijfer S.... de Wit R.
|30|Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review. (12435371)
Shelley M.D.... Mason M.D.
|31|Dramatic response of teratoma-associated non--germ-cell cancer with all-trans retinoic acid in a patient with nonseminomatous germ cell tumor. (11407397)
Gordon M.S.... Einhorn L.H.
|32|Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. (10856101)
Motzer R.J.... Bosl G.J.
|33|Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer. (10552153)
Hartmann J.T.... Bokemeyer C.
|34|A molecular model for the development of germ cell cancer. (10597200)
Looijenga L.H.... Oosterhuis J.W.
|35|BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG) (10355572)
GermA -Lluch J.R.... Barnadas A.
|36|Germ cell cancer and dermatomyositis. (9543617)
Clayton A.J.... Mead G.M.
|37|Testicular germ-cell cancer. (9227931)
Bosl G.J.... Motzer R.J.
|38|Fertility after chemotherapy for testicular germ cell cancer. (9207575)
Pont J.... Albrecht W.
|39|Gonadal function after multimodality treatment in men with testicular germ cell cancer. (8640293)
Palmieri G.... Torino G.
|40|Results of postchemotherapy adjunctive retroperitoneal lymph node dissection in non-seminomatous germ cell cancer patients. (8961487)
Goepel M.... RA1bben H.
|41|Pilot study of a high-dose carboplatin-based salvage strategy for relapsing or refractory germ cell cancer. (7627721)
Rodenhuis S.... Vlasveld L.T.
|42|High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group. (7911158)
Siegert W.... Huhn D.
|43|Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. (8075033)
Petersen P.M.... Skakkebaek N.E.
|44|High-dose epirubicin in chemotherapy refractory non-seminomatous germ cell cancer: a phase II study. EORTC Genito-Urinary Tract Cancer Co-operative Group. EORTC Early Clinical Trials Group. (1323325)
Stoter G.... Van Glabbeke M.
|45|Management of patients with poor-prognosis nonseminomatous germ cell cancer. (1692984)
FossAY S.D.... Blomlie V.
|46|Long-term fertility and Leydig cell function in patients treated for germ cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance. (1698935)
Hansen S.W.... von der Maase H.
|47|Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. (2544687)
Nichols C.R.... Wolff S.N.
|48|Metastatic germ cell cancer--a curable neoplasm. (2681625)
|49|Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer. (2460594)
Hansen S.W.... rth M.
|50|Poorly differentiated carcinoma or extragonadal germ cell cancer. (3032035)
Gonzalez Vela J.L.... Panasci L.C.